Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 726,527 shares of the healthcare conglomerate's stock, valued at approximately $367,521,000. UnitedHealth Group makes up 0.7% of Universal Beteiligungs und Servicegesellschaft mbH's investment portfolio, making the stock its 17th largest holding. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.08% of UnitedHealth Group at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at about $28,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In other UnitedHealth Group news, Director John H. Noseworthy acquired 300 shares of the firm's stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the acquisition, the director now owns 6,063 shares in the company, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 109,408 shares of company stock worth $31,607,768. Insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Down 0.2%

Shares of NYSE:UNH traded down $0.58 during trading on Tuesday, reaching $294.99. The stock had a trading volume of 20,069,744 shares, compared to its average volume of 6,655,522. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The firm's 50-day simple moving average is $448.25 and its 200 day simple moving average is $501.48. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $267.60 billion, a P/E ratio of 19.03, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the prior year, the company posted $6.91 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on UNH. Morgan Stanley lowered their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. JPMorgan Chase & Co. reduced their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research report on Thursday, May 15th. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a report on Monday, May 19th. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Finally, Erste Group Bank cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $441.87.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.